ASSOCIATION BETWEEN PLATELET-TO-LYMPHOCYTE RATIO AND CLINICAL CHARACTERISTICS AND TREATMENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Main Article Content
Abstract
Background: Acute myocardial infarction (AMI) is a leading cause of cardiovascular mortality in Viet Nam. Although prognostic scoring systems and cardiac biomarkers have contributed substantially to improving outcomes, in-hospital adverse events remain common, especially in primary and lower-level healthcare settings. Therefore, simpler and more practical prognostic tools are needed. Objective: To investigate the association between the platelet-to-lymphocyte ratio (PLR) and clinical, paraclinical characteristics, as well as treatment strategies, in patients with AMI. Methods: This was a retrospective analytical study on 112 patients with AMI admitted to the Interventional Cardiology Department, University Medical Center Ho Chi Minh City, from January 2023 to January 2025. Patients were stratified into two groups according to PLR values (>153 vs. ≤153). Results: Compared with the low-PLR group, patients with high PLR had higher heart rates (91.5 vs. 83.7 bpm), lower blood pressures, a higher proportion of STEMI (76.1% vs. 35.6%), more Killip class ≥ II (47.8% vs. 13.3%), and more GRACE high-risk scores (44.8% vs. 20%). High-PLR patients also showed higher levels of high-sensitivity troponin T, NT-proBNP, glucose, and creatinine, and lower eGFR. They more frequently received spironolactone (73.1% vs. 26.7%), dobutamine (32.8% vs. 8.9%), and noradrenaline (26.9% vs. 8.9%). Conclusion: High PLR is associated with more severe clinical presentation and increased need for intensive supportive therapy among patients with AMI. PLR may serve as a simple and practical prognostic marker in routine clinical practice
Article Details
Keywords
PLR, platelet-to-lymphocyte ratio, acute myocardial infarction
References
2. Zhang L, Tong Z, Han R, et al. Global, Regional, and National Burdens of Ischemic Heart Disease Attributable to Smoking From 1990 to 2019. J Am Heart Assoc. Feb 7 2023;12(3): e028193. doi:10.1161/jaha.122. 028193
3. Şahin B, İlgün G. Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries. Health Soc Care Community. Jan 2022;30(1):73–80. doi:10.1111/hsc.13156
4. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. Oct 12 2023; 44(38): 3720–3826. doi:10.1093/eurheartj/ ehad191
5. Chen Y, Chen S, Han Y, Xu Q, Zheng M, Zhao X. A combined index constructed based on NLR and PLR is associated with in-hospital mortality risk in patients with acute myocardial infarction. Am J Transl Res. 2023;15(6):4118–4128.
6. Liu J, Ao W, Zhou J, Luo P, Wang Q, Xiang D. The correlation between PLR-NLR and prognosis in acute myocardial infarction. Am J Transl Res. 2021;13(5):4892–4899.
7. Wang H, Li L, Ma Y. Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study. Clin Cardiol.Jun 2023;46(6):632–638. doi:10.1002/ clc.24002
8. Temiz A, Gazi E, Güngör Ö, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. Apr 22 2014;20:660–5. doi:10.12659/msm.890152
9. Willim HA, Harianto JC, Cipta H. Platelet-to-Lymphocyte Ratio at Admission as a Predictor of In-Hospital and Long-Term Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Cardiol Res. Apr 2021;12(2):109–116. doi:10.14740/cr1219
10. Zhou D, Fan Y, Wan Z, et al. Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome. Cardiology. 2016;134(1):39–46. doi:10.1159/000442939